Patent application number | Description | Published |
20130171938 | HANDHELD DIABETES MANAGER WITH AUTOMATED DISCONNECT FEATURE - A computer-implemented method is provided for a handheld diabetes-management device to establish a data connection with a Continua manager. The method includes: receiving a request to establish a new data connection with a computing device, where the computing device is physically separated from the diabetes-management device and operates as a manager in accordance with IEEE standard 11073; determining whether the diabetes-management device has an existing data connection with a medical device that is physically separated from the diabetes-management device; terminating the existing data connection with the medical device in response to the determination that the diabetes-management device has an existing connection with the medical device; and establishing a new data connection with the computing device in accordance with IEEE standard 11073. | 07-04-2013 |
20130172707 | GRAPHICAL USER INTERFACE PERTAINING TO A BOLUS CALCULATOR RESIDING ON A HANDHELD DIABETES MANAGEMENT DEVICE - A handheld diabetes manager is presented with an improved graphical user interface for a bolus calculator. The bolus calculator is configured to receive blood glucose measurements from a blood glucose measurement module and operates, in response to an input, to compute an insulin recommendation for a patient based in part on the blood glucose measurements. The graphical user interface for the bolus calculator includes a health adjustment screen that enables a user to input a value for health events associated with the insulin recommendation, where the input value represents a cumulative effect of the health events on insulin of the patient and the health adjustment screen presents a different icon for each of the health events associated with the insulin recommendation. | 07-04-2013 |
20130172708 | Handheld Diabetes Manager With A User Interface For Displaying A Status Of An External Medical Device - A handheld diabetes manager has a graphical user interface for displaying status of an external medical device and includes a port configured to receive a test strip and a blood glucose measurement module. The diabetes manager includes a communications module that selectively communicates via a wireless data link with an external medical device to receive status data pertaining to the operation of the external medical device, and a user interface module in data communication with the blood glucose measurement module and the communications module. The graphical user interface includes a status screen that presents data pertaining to a glucose measure determined by the blood glucose measurement module concurrently with the status data received from the external medical device, such that the status data of the external medical device is presented on the status screen only when the communication module is in data communication with the external medical device. | 07-04-2013 |
20130172709 | Handheld Diabetes Manager With A Flight Mode - A handheld diabetes manager has a flight mode that cooperatively interacts with an external medical device and includes a port configured to receive a test strip for blood glucose measurement, a blood glucose measurement module operable with the test strip, a communications module and a user interface module. The communications module selectively communicates wirelessly with an external medical device. The user interface module communicates with the blood glucose measurement module and the communications module and operates to provide a graphical user interface on a display of the diabetes manager. The graphical user interface includes a screen with a flight mode option. When the flight mode option is enabled and the external medical device is paired and currently communicating with the diabetes manager, the user interface module interacts with the communication module to send a command to the external medical device to turn off wireless communication of the external medical device. | 07-04-2013 |
20130172710 | Handheld Diabetes Manager With A Personal Data Module - A handheld diabetes manager communicates with an external insulin pump and includes a port for blood glucose measurement, a blood glucose measurement module, a communications module that selectively communicates wirelessly with the insulin pump, and a user interface module. The user interface module communicates with the blood glucose measurement module and the communications module and operates to provide a graphical user interface on a display of the diabetes manager. The graphical user interface includes a personal data menu screen from which a logbook option can be selected to display a logbook screen, and a trend graph option that can be selected to display a trend graph screen. The logbook screen displays a plurality of time data records. Each time data record includes blood glucose data, bolus insulin data, and carbohydrate data for a corresponding time, and a plurality of data icons indicating corresponding events. | 07-04-2013 |
Patent application number | Description | Published |
20100157732 | Time Reverse Reservoir Localization - A method and system for processing synchronous array seismic data includes acquiring synchronous passive seismic data from a plurality of sensors to obtain synchronized array measurements. A reverse-time data process is applied to the synchronized array measurements to obtain a plurality of dynamic particle parameters associated with subsurface locations. These dynamic particle parameters are stored in a form for display. Maximum values of the dynamic particle parameters may be interpreted as reservoir locations. The dynamic particle parameters may be particle displacement values, particle velocity values, particle acceleration values or particle pressure values. The sensors may be three-component sensors. Zero-phase frequency filtering of different ranges of interest may be applied. The data may be resampled to facilitate efficient data processing. | 06-24-2010 |
20100161234 | Time Reverse Reservoir Localization - A method and system for processing synchronous array seismic data includes acquiring synchronous passive seismic data from a plurality of sensors to obtain synchronized array measurements. A reverse-time data process is applied to the synchronized array measurements to obtain a plurality of dynamic particle parameters associated with subsurface locations. These dynamic particle parameters are stored in a form for display. Maximum values of the dynamic particle parameters may be interpreted as reservoir locations. The dynamic particle parameters may be particle displacement values, particle velocity values, particle acceleration values or particle pressure values. The sensors may be three-component sensors. Zero-phase frequency filtering of different ranges of interest may be applied. The data may be resampled to facilitate efficient data processing. | 06-24-2010 |
20110286305 | TIME REVERSE IMAGING OPERATORS FOR SOURCE LOCATION - A method and system for processing synchronous array seismic data includes acquiring synchronous passive seismic data from a plurality of sensors to obtain synchronized array measurements. A reverse-time data propagation process is applied to the synchronized array measurements to obtain a plurality of dynamic particle parameters associated with subsurface locations. Imaging conditions are applied to the dynamic particle parameters to obtain image values associated with subsurface energy source locations. | 11-24-2011 |
20120014214 | TIME REVERSE IMAGING OPERATORS FOR SOURCE LOCATION WITH BOREHOLE DATA - A method and system for processing synchronous array seismic data includes acquiring synchronous passive seismic data from a plurality of sensors to obtain synchronized array measurements. A reverse-time data propagation process is applied to the synchronized array measurements to obtain a plurality of dynamic particle parameters associated with subsurface locations. Imaging conditions are applied to the dynamic particle parameters to obtain image values associated with subsurface energy source locations. | 01-19-2012 |
20120014215 | Time reverse reservoir localization with borehole data - A method and system for processing synchronous array seismic data includes acquiring synchronous passive seismic data from a plurality of sensors to obtain synchronized array measurements. A reverse-time data process is applied to the synchronized array measurements to obtain a plurality of dynamic particle parameters associated with subsurface locations. These dynamic particle parameters are stored in a form for display. Maximum values of the dynamic particle parameters may be interpreted as reservoir locations. The dynamic particle parameters may be particle displacement values, particle velocity values, particle acceleration values or particle pressure values. The sensors may be three-component sensors. Zero-phase frequency filtering of different ranges of interest may be applied. The data may be resampled to facilitate efficient data processing. | 01-19-2012 |
20120014216 | Time reverse reservoir localization - A method and system for processing synchronous array seismic data includes acquiring synchronous passive seismic data from a plurality of sensors to obtain synchronized array measurements. A reverse-time data process is applied to the synchronized array measurements to obtain a plurality of dynamic particle parameters associated with subsurface locations. These dynamic particle parameters are stored in a form for display. Maximum values of the dynamic particle parameters may be interpreted as reservoir locations. The dynamic particle parameters may be particle displacement values, particle velocity values, particle acceleration values or particle pressure values. The sensors may be three-component sensors. Zero-phase frequency filtering of different ranges of interest may be applied. The data may be resampled to facilitate efficient data processing. | 01-19-2012 |
Patent application number | Description | Published |
20110137186 | DEVICE FOR MEASURING THE BLOOD FLOW OF A BODY TISSUE - A device for measuring the blood flow of a body tissue comprises a catheter having a catheter head for the insertion into the inside of a body tissue and a center piece having a light emission surface, out of which an optical conductor leads, and having a reflection surface, which is disposed opposite of the light emission surface and oriented obliquely to the longitudinal axis of the optical conductor. The optical conductor is disposed such that an emitted light beam is directed at the reflection surface, the emitted light beam can be deflected at the reflection surface and reflected into the body tissue, and a reflected light beam can be reflected out of the body tissue at the reflection surface and fed into the optical conductor. The catheter head is divided into an insertion region and a connecting region, wherein the insertion region comprises a plurality of recesses on the surface thereof. In the direction of the connecting region, the insertion region has an increasing diameter. The recesses are provided in the insertion region such that webs are formed in the direction of the connecting region between the recesses along the surface of the catheter head. | 06-09-2011 |
20120078295 | OCCLUDER - The invention relates to an occluder for closing a passage in a circulatory system comprising an expandable fixation unit for fixing the occluder on the passage, wherein the occluder can be transferred in the passage from a compact appearance into an expanded appearance. The occluder has a distal and a proximal axial part, in which the fixation unit is pivotally held. According to the invention, the fixation unit comprises distal fixation arms and proximal fixation arms, wherein the distal fixation arms are pivotally held in the distal axial part and the proximal fixation arms are pivotally held in the proximal axial part. The distal and the proximal fixation arms have free ends, which are interconnected by means of connecting members that can be moved relative to the fixation arms, wherein in each case a distal fixation arm is connected to a proximal fixation arm located diagonally opposed thereto. Said occluder is suited in particular for closing a ventricular septal defect (VSD). | 03-29-2012 |
20120245529 | ANCHORING DEVICE FOR A LINE IN A SKULL BORE HOLE - An anchoring device for anchoring a line in a skull bore hole comprises a base part and a cover that tightly closes the base part. The base part has a fastening element for fastening the base part in the bore hole and a passage opening for feeding the line from the bore hole to an outside of the anchoring device. A contact surface extending between the bore hole and the outside for laying the line is present in the base part. The contact surface is curved in a constant direction so that the line is guided from the skull interior to the outside in a constant direction and at a radius of curvature that is greater than or equal to a predefined minimum radius of curvature. Said anchoring device allows a line to be lead out of a bore hole of a skull at a flat angle without the line being bent too greatly or even kinked. | 09-27-2012 |
20150257705 | Catheter for Measuring the Blood Flow of a Body Tissue - A catheter for measuring a flow of blood through a body tissue comprises a light emitter for emitting light into the body tissue and at least one light receiver for receiving light reflected in the body tissue and back to the catheter. The light emitter and the at least one light receiver are arranged in the catheter, wherein the catheter comprises a middle piece and a first and a second connection tube. The middle piece has a distal fastening piece for fastening to the first connection tube and a proximal fastening piece for fastening to the second connection tube, wherein the light emitter and the at least one light receiver are arranged in the middle piece. | 09-17-2015 |
Patent application number | Description | Published |
20110118146 | Phage Display Using Cotranslational Translocation of Fusion Polypeptides - The present invention relates to a filamentous phage display method wherein the polypeptides of interest displayed on the phage particle are cotranslationally translocated across the cytoplasmic membrane of Gram-negative bacteria based on the signal recognition particle pathway. This method is particularly suitable for polypeptides, which are known to be difficult to display on phages, and for proteins of cDNA libraries and other combinatorial libraries, in particular when derived from very fast folding, stable protein scaffolds. The invention further relates to phage or phagemid vectors useful in the method comprising a gene construct coding for a fusion polypeptide comprising the polypeptide to be displayed on the phage particle and an N-terminal signal sequence promoting cotranslational translocation. | 05-19-2011 |
20130244940 | DESIGNED REPEAT PROTEINS BINDING TO SERUM ALBUMIN - New designed repeat proteins with binding specificity for serum albumin are described, as well as nucleic acids encoding such serum albumin binding proteins, pharmaceutical compositions comprising such proteins, the use of such proteins to modify the pharmacokinetics of therapeutic relevant polypeptides and the use of such proteins in the treatment of diseases. The repeat proteins of the invention have a substantially increased half-life in plasma compared to proteins not binding serum albumin. | 09-19-2013 |
20150057186 | PHAGE DISPLAY USING COTRANSLATIONAL TRANSLOCATION OF FUSION POLYPEPTIDES - The present invention relates to a filamentous phage display method wherein the polypeptides of interest displayed on the phage particle are cotranslationally translocated across the cytoplasmic membrane of Gram-negative bacteria based on the signal recognition particle pathway. This method is particularly suitable for polypeptides, which are known to be difficult to display on phages, and for proteins of cDNA libraries and other combinatorial libraries, in particular when derived from very fast folding, stable protein scaffolds. The invention further relates to phage or phagemid vectors useful in the method comprising a gene construct coding for a fusion polypeptide comprising the polypeptide to be displayed on the phage particle and an N-terminal signal sequence promoting cotranslational translocation. | 02-26-2015 |
Patent application number | Description | Published |
20080280929 | Antifungal Wallboards and Building Materials and Methods for the Production Thereof - The present invention relates to, inter alia, methods for the treatment of wallboards and the treated wallboards. In particular, the invention relates to the treatment of wallboards with a fungicidally effective amount of a strobilurin or strobilurin-type fungicide. In a particular embodiment the fungicide is azoxystrobin. The invention also provides for the treatment of wallboards and building materials with combinations of fungicides present in synergistic amounts. | 11-13-2008 |
20080306119 | Method for the Protection of Materials - The present invention relates to the use of the compound A) 4-(2,2-difluoro-1,3-benzodioxol-4-yl)pyrrole-3-carbonitrile(fludioxonil) as a microbicide for the protection of engineering or industrial materials, to mixtures containing such compound, and to the use of such mixtures for the protection of engineering or industrial materials. | 12-11-2008 |
20090297571 | ANTIFUNGAL WALLBOARDS AND BUILDING MATERIALS AND METHODS FOR THE PRODUCTION THEREOF - The present invention relates to, inter alia, methods for the treatment of wallboards with fungicides and the treated wallboards. In particular, the invention relates to the treatment of wallboards with a fungicidally effective amount of fludioxonil. The invention also provides for the treatment of wallboards with synergistic combinations of fludioxonil and other fungicides. The invention also provides the treatment of building materials with fludioxonil and synergistic mixtures containing fludioxonil. | 12-03-2009 |
20090298860 | ANTIFUNGAL WALLBOARDS AND BUILDING MATERIALS AND METHODS FOR THE PRODUCTION THEREOF - The present invention relates to, inter alia, methods for the treatment of wallboards with fungicides and the treated wallboards. In particular, the invention relates to the treatment of wallboards with a fungicidally effective amount of difenoconazole. The invention also provides for the treatment of wallboards with synergistic combinations of difenoconazole and other fungicides. The invention also provides the treatment of building materials with difenoconazole and synergistic mixtures containing difenoconazole. | 12-03-2009 |
Patent application number | Description | Published |
20110294978 | PROCESS AND A DEVICE FOR THE CONTINUOUS TREATMENT OF MIXED SUBSTANCES - A process for the continuous thermal treatment of mixed substances, especially of solutions, suspensions and emulsions, wherein the continuous treatment of the mixed substances is divided into a main vaporization and a degassing stage, in which instance the main vaporization and the degassing take place in each case takes place in a separate mixer-kneader. | 12-01-2011 |
20120140587 | METHOD FOR TREATING A MONOMER, PRE-POLYMER, POLYMER OR A CORRESPONDING MIXTURE - The invention relates to a method for treating a monomer, pre-polymer, polymer or a corresponding mixture, in particular for producing a dope for producing a polymer fibre, in particular a p-aramide fibre, in which the monomer, pre-polymer, polymer, additives or a corresponding mixture is admixed with a solvent, blended, fused, homogenised and/or degassed and then discharged, which takes place at least partially in a reactor ( | 06-07-2012 |
20130093112 | PROCESS FOR PRODUCING A PRODUCT - A method for production of a molded article from a base substance in a device for mixing of the base substance with a solvent is provided. The method includes mixing a base substance to produce a molding solution with the solvent and at least partially removing the solvent from the mixture; and feeding the molding solution to a device for further processing of a product and diluting the molding solution before further processing. In embodiments, the diluent is introduced to the device before a discharge device and/or in the discharge device. | 04-18-2013 |
20130153158 | PROCESS FOR THERMAL SEPARATION OF A SOLUTION CONSISTING OF THERMOPLASTIC POLYMER AND SOLVENT - A process for thermal separation of a solution comprised of a thermoplastic polymer and a solvent involves heating a solvent under pressure above a critical point of the solvent; decompressing the heated solvent in a first vessel, such that a polymer-rich and a low-polymer phase form; and supplying the polymer-rich phase to a second vessel. In embodiments, on entry into the second vessel, a pressure jump occurs, the pressure jump leading to a thermal flash in the second vessel such that a polymer part of the polymer-rich phase rises to at least 70%, and a resulting polymer-rich solution is provided. | 06-20-2013 |
20150298022 | PROCESS FOR THERMAL SEPARATION OF A SOLUTION - A process for thermal separation of a solution comprised of a thermoplastic polymer and a solvent involves heating a solvent under pressure above a critical point of the solvent; decompressing the heated solvent in a first vessel, such that a polymer-rich and a low-polymer phase form; and supplying the polymer-rich phase to a second vessel. In embodiments, on entry into the second vessel, a pressure jump occurs, the pressure jump leading to a thermal flash in the second vessel such that a polymer part of the polymer-rich phase rises to at least 70%, and a resulting polymer-rich solution is provided. | 10-22-2015 |
Patent application number | Description | Published |
20100028269 | DRY POWDER FORMULATIONS - A dry powder suitable for inhalation in a dry powder inhaler, the powder comprising a carrier, an active agent and at least 0.5% by weight of magnesium stearate, the powder being further characterized in that the less than 10% of the surface of the carrier material is covered with particles of magnesium stearate. The invention is also directed to a method of making dry powders by blending together the ingredients mentioned in a diffusion blender for a period time that is less than 60 minutes. | 02-04-2010 |
20100035854 | DRY POWDER FORMULATIONS - A dry powder suitable for inhalation in a dry powder inhaler, the powder comprising a carrier, an active agent and at least 0.5% by weight of magnesium stearate, the powder being further characterized in that the less than 10% of the surface of the carrier material is covered with particles of magnesium stearate. The invention is also directed to a method of making dry powders by blending together the ingredients mentioned in a diffusion blender for a period time that is less than 60 minutes. | 02-11-2010 |
20120107406 | Dry Powder Formulations - A dry powder suitable for inhalation n a dry powder inhaler, the powder comprising a carrier, an active agent and at least 0.5% by weight of magnesium stearate, the powder being further characterized in that the less than 10% of the surface of the carrier material is covered with particles of magnesium stearate. The invention is also directed to a method of making dry powders by blending together the ingredients mentioned in a diffusion blender for a period of time that is less than 60 minutes. | 05-03-2012 |
20130014758 | DRY POWDER FORMULATIONS - A dry powder suitable for inhalation n a dry powder inhaler, the powder comprising a carrier, an active agent and at least 0.5% by weight of magnesium stearate, the powder being further characterized in that the less than 10% of the surface of the carrier material is covered with particles of magnesium stearate. The invention is also directed to a method of making dry powders by blending together the ingredients mentioned in a diffusion blender for a period of time that is less than 60 minutes. | 01-17-2013 |